Literature DB >> 18483468

Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases.

Melissa D Shelton1, John J Mieyal.   

Abstract

S-glutathionylation is a reversible post-translational modification that continues to gain eminence as a redox regulatory mechanism of protein activity and associated cellular functions. Many diverse cellular proteins such as transcription factors, adhesion molecules, enzymes, and cytokines are reported to undergo glutathionylation, although the functional impact has been less well characterized. De-glutathionylation is catalyzed specifically and efficiently by glutaredoxin (GRx, aka thioltransferase), and facile reversibility is critical in determining the physiological relevance of glutathionylation as a means of protein regulation. Thus, studies with cohesive themes addressing both the glutathionylation of proteins and the corresponding impact of GRx are especially useful in advancing understanding. Reactive oxygen species (ROS) and redox regulation are well accepted as playing a role in inflammatory processes, such as leukostasis and the destruction of foreign particles by macrophages. We discuss in this review the current implications of GRx and/or glutathionylation in the inflammatory response and in diseases associated with chronic inflammation, namely diabetes, atherosclerosis, inflammatory lung disease, cancer, and Alzheimer's disease, and in viral infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483468      PMCID: PMC3367451     

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  104 in total

1.  Molecular mechanism of glutathione-mediated protection from oxidized low-density lipoprotein-induced cell injury in human macrophages: role of glutathione reductase and glutaredoxin.

Authors:  Yanmei Wang; Mu Qiao; John J Mieyal; Lars M Asmis; Reto Asmis
Journal:  Free Radic Biol Med       Date:  2006-06-03       Impact factor: 7.376

2.  Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.

Authors:  Niki L Reynaert; Albert van der Vliet; Amy S Guala; Toby McGovern; Milena Hristova; Cristen Pantano; Nicholas H Heintz; John Heim; Ye-Shih Ho; Dwight E Matthews; Emiel F M Wouters; Yvonne M W Janssen-Heininger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

3.  Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis.

Authors:  D M Shih; Y R Xia; X P Wang; E Miller; L W Castellani; G Subbanagounder; H Cheroutre; K F Faull; J A Berliner; J L Witztum; A J Lusis
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

4.  Acute cadmium exposure inactivates thioltransferase (Glutaredoxin), inhibits intracellular reduction of protein-glutathionyl-mixed disulfides, and initiates apoptosis.

Authors:  C A Chrestensen; D W Starke; J J Mieyal
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

Review 5.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

6.  Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1.

Authors:  C Xiao; C M Bator; V D Bowman; E Rieder; Y He; B Hébert; J Bella; T S Baker; E Wimmer; R J Kuhn; M G Rossmann
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells.

Authors:  K Hirota; M Matsui; M Murata; Y Takashima; F S Cheng; T Itoh; K Fukuda; J Yodoi; Y Junji
Journal:  Biochem Biophys Res Commun       Date:  2000-07-21       Impact factor: 3.575

8.  Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation: the origin and role of urinary sICAM-1?

Authors:  A M Teppo; E von Willebrand; E Honkanen; J Ahonen; C Grönhagen-Riska
Journal:  Transplantation       Date:  2001-04-27       Impact factor: 4.939

9.  Oxidant-induced S-glutathiolation inactivates protein kinase C-alpha (PKC-alpha): a potential mechanism of PKC isozyme regulation.

Authors:  N E Ward; J R Stewart; C G Ioannides; C A O'Brian
Journal:  Biochemistry       Date:  2000-08-22       Impact factor: 3.162

10.  Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease.

Authors:  S Akterin; R F Cowburn; A Miranda-Vizuete; A Jiménez; N Bogdanovic; B Winblad; A Cedazo-Minguez
Journal:  Cell Death Differ       Date:  2005-11-25       Impact factor: 15.828

View more
  59 in total

1.  Glutathionylation in the photosynthetic model organism Chlamydomonas reinhardtii: a proteomic survey.

Authors:  Mirko Zaffagnini; Mariette Bedhomme; Hayam Groni; Christophe H Marchand; Carine Puppo; Brigitte Gontero; Corinne Cassier-Chauvat; Paulette Decottignies; Stéphane D Lemaire
Journal:  Mol Cell Proteomics       Date:  2011-11-28       Impact factor: 5.911

Review 2.  Glutathione and modulation of cell apoptosis.

Authors:  Magdalena L Circu; Tak Yee Aw
Journal:  Biochim Biophys Acta       Date:  2012-06-23

3.  Proteomic identification and quantification of S-glutathionylation in mouse macrophages using resin-assisted enrichment and isobaric labeling.

Authors:  Dian Su; Matthew J Gaffrey; Jia Guo; Kayla E Hatchell; Rosalie K Chu; Therese R W Clauss; Joshua T Aldrich; Si Wu; Sam Purvine; David G Camp; Richard D Smith; Brian D Thrall; Wei-Jun Qian
Journal:  Free Radic Biol Med       Date:  2013-12-11       Impact factor: 7.376

Review 4.  Protein-thiol oxidation and cell death: regulatory role of glutaredoxins.

Authors:  Erin M G Allen; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2012-06-05       Impact factor: 8.401

Review 5.  S-glutathionylation of ion channels: insights into the regulation of channel functions, thiol modification crosstalk, and mechanosensing.

Authors:  Yang Yang; Xin Jin; Chun Jiang
Journal:  Antioxid Redox Signal       Date:  2013-08-20       Impact factor: 8.401

6.  Glutaredoxin 1 regulates cigarette smoke-mediated lung inflammation through differential modulation of I{kappa}B kinases in mice: impact on histone acetylation.

Authors:  Sangwoon Chung; Isaac Kirubakaran Sundar; Hongwei Yao; Ye-Shih Ho; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-05-14       Impact factor: 5.464

Review 7.  Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system.

Authors:  David Pimentel; Dagmar Johanna Haeussler; Reiko Matsui; Joseph Robert Burgoyne; Richard Alan Cohen; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-03-15       Impact factor: 8.401

8.  The glutaredoxin/S-glutathionylation axis regulates interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with S-glutathionylation of nuclear factor κB family proteins.

Authors:  James D Nolin; Jane E Tully; Sidra M Hoffman; Amy S Guala; Jos L van der Velden; Matthew E Poynter; Albert van der Vliet; Vikas Anathy; Yvonne M W Janssen-Heininger
Journal:  Free Radic Biol Med       Date:  2014-05-09       Impact factor: 7.376

9.  Cysteinyl-glycine in the control of glutathione homeostasis in bovine lenses.

Authors:  Gian Marco De Donatis; Roberta Moschini; Mario Cappiello; Antonella Del Corso; Umberto Mura
Journal:  Mol Vis       Date:  2010-06-05       Impact factor: 2.367

10.  Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation.

Authors:  Gerd Birkenmeier; Christin Stegemann; Ralf Hoffmann; Robert Günther; Klaus Huse; Claudia Birkemeyer
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.